
Topic
Payer Policy
Medicare, commercial payer, PBM, and formulary-policy moves that shape launch curves and gross-to-net.

Specialty· August 30, 2026 · 23 min read

Approvals· August 30, 2026 · 16 min read
Mounjaro's CV Claim Is Noninferiority vs Trulicity, Not Placebo Superiority
By Ran Chen#GLP-1#GIP/GLP-1#Diabetes and Obesity

Evidence· August 29, 2026 · 23 min read
Treatment-Regimen Estimands in FDA Labels: Answering the Real Coverage Question
By Ran Chen#Clinical Evidence#Clinical Trials#FDA

Policy· August 24, 2026 · 20 min read
HHS Vaccine-Category RFI: What SCDM Means for ACA and VFC Coverage Clocks
By Ran Chen#Policy#Coverage Access#Payer Policy

Generics· August 22, 2026 · 17 min read
FDA's August 2026 PSG Batch: Development Clock vs Orange Book Exclusivity
By Ran Chen#Generics#Orange Book#FDA

Policy· August 20, 2026 · 19 min read
CMS-4215-P Comment Docket: Manufacturers and Hospitals Clash on IRA Rules
By Ran Chen#IRA Negotiation#Policy#Payer Policy

Pricing & Access· August 20, 2026 · 21 min read
Prescription Drug Prices Posted Steepest Drop Since 1963: What CPI Measures

Policy· August 19, 2026 · 18 min read
CMS Bona Fide Marketing Rule: What the D.C. Circuit Teva Ruling Actually Revived
By Ran Chen#Policy#IRA Negotiation#Medicare Part D

Pricing & Access· August 17, 2026 · 25 min read
Medicaid's September 10 Deadline: The Coverage Trade for GENEROUS Pricing
By Ran Chen#Medicaid#Drug Pricing#Payer Policy

Pricing & Access· August 17, 2026 · 25 min read